Home   Business   Article

Subscribe Now

£5m Cambridge hub will research inflammatory bowel disease using genomics



More news, no ads

LEARN MORE


Enterobacteriaceae, gram-negative rod-shaped bacteria, are part of the intestinal microbiome and are causative agents of different disorders
Enterobacteriaceae, gram-negative rod-shaped bacteria, are part of the intestinal microbiome and are causative agents of different disorders

Patients living with Crohn’s and colitis will be the first to benefit from a £5million grant for a new research hub in Cambridge.

The grant has been awarded by Health Data Research UK (HDR UK) to establish a data research hub for inflammatory bowel disease (IBD) following a successful bid led by Eastern AHSN and Cambridge University Health Partners (CUHP).

The Cambridge-based hub will be one of seven hubs set up across the UK to speed up research for new medicines and treatments, support quicker diagnoses and potentially save lives. The six other hubs focus on different conditions including cancer, eye health and respiratory conditions.



This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies - Learn More